937814-63-6

Upstream product

• 937814-59-0 (R)-2-tert-butoxycarbonylamino-5-(4-chlorophenyl)-5-oxopentanoic acid ethyl ester 
• 68766-96-1 ethyl (R)-2-pyrrolidone-5-carboxylate 
• 144978-12-1 1-tert-butyl 2-ethyl (2R)-5-oxopyrrolidine-1,2-dicarboxylate 

Downstream Products

• 937814-62-5 (2R,5S)-5-(4-chlorophenyl)pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-ethyl ester 
• 1050393-41-3 (Z)-(1S,6S,8aR)-6-(4-chlorophenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)benzylidene]-1-methyltetrahydropyrrolo[2,1-c][1,4]oxazin-4-one 
• 1050393-28-6 (2S,5R)-2-(4-chlorophenyl)-5-((S)-1-hydroxyethyl)-pyrrolidine-1-carboxylic acid t-butyl ester 
• 937814-65-8 (2S,5R)-2-(4-chlorophenyl)-5-hydroxymethyl-pyrrolidine-1-carboxylic acid t-butyl ester 
• 937814-66-9 C₁₆H₂₀ClNO₃ 
• 1050393-36-6 (1S,6S,8aR)-6-(4-chlorophenyl)-1-methyltetrahydropyrrolo[2,1-c][1,4]oxazine-3,4-dione 
• 1050393-32-2 (S)-1-[(2R,5S)-5-(4-chlorophenyl)pyrrolidine-2-yl]ethanol 

Relevant academic research and scientific papers

TWO CYCLIC OXOMORPHORIN DERIVATIVES

The present invention relates to a compound represented by formula (I): wherein R1 represents a C1-3 alkyl group, R2 represents a hydrogen atom or a C1-3 alkyl group, Ar represents a phenyl group or the like which may be substituted with 1 to 3 substituents, X represents an oxygen atom or the like, n and m are the same or different and integers of 0 to 2, or a pharmacologically acceptable salt, and use thereof as a medicament.